Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M604039200 on August 14, 2006

J. Biol. Chem., Vol. 281, Issue 42, 31298-31308, October 20, 2006
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
281/42/31298    most recent
M604039200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gao, S.
Right arrow Articles by Hazen, S. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gao, S.
Right arrow Articles by Hazen, S. L.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Phospholipid Hydroxyalkenals, a Subset of Recently Discovered Endogenous CD36 Ligands, Spontaneously Generate Novel Furan-containing Phospholipids Lacking CD36 Binding Activity in Vivo*

Shengqiang Gao{ddagger}§1, Renliang Zhang{ddagger}§, Michael E. Greenberg{ddagger}§, Mingjiang Sun{ddagger}§, Xi Chen, Bruce S. Levison{ddagger}§, Robert G. Salomon, and Stanley L. Hazen{ddagger}§||2

From the Departments of {ddagger}Cell Biology and ||Cardiovascular Medicine and the §Center for Cardiovascular Diagnostics and Prevention, Cleveland Clinic Foundation, Cleveland, Ohio 44195 and the Department of Chemistry, Case Western Reserve University, Cleveland, Ohio 44106

We recently identified a novel family of oxidized choline glycerophospholipid (oxPC) molecular species enriched in atheroma that serve as endogenous ligands for the scavenger receptor CD36 (oxPCCD36), facilitating macrophage cholesterol accumulation and foam cell formation (Podrez, E. A., Poliakov, E., Shen, Z., et al. (2002) J. Biol. Chem. 277, 38517–38523). A high affinity CD36 recognition motif was defined within oxPCCD36, an oxidatively truncated sn-2 acyl group with a terminal {gamma}-hydroxy (or oxo)-{alpha},beta-unsaturated carbonyl. The fate of these species once formed in vivo is unknown. Here we show that a subset of oxPCCD36, a phosphatidylcholine molecular species possessing sn-2 esterified fatty acyl hydroxyalkenal groups, can undergo a slow intramolecular cyclization and dehydration reaction to form novel oxPC species possessing a sn-2 acyl group that incorporates a terminal furyl moiety (oxPC-furan). Using high performance liquid chromatography with on-line tandem mass spectrometry in combination with unambiguous organic synthesis, we confirm that oxPC-furans, ultimately derived from phospholipids with sn-2 esterified docosahexaenoic, arachidonic, or linoleic acids, are formed during exposure of model membranes and isolated lipoproteins to physiological oxidant systems. In vivo generation of oxPC-furans at sites of enhanced oxidant stress is also demonstrated, such as within brain tissues following cerebral ischemia. Cell binding studies reveal that in contrast to their oxPCCD36 precursors, oxPC-furans lack CD36 binding activity. Taken together, the present studies identify oxPC-furans as a novel family of oxidized phospholipids that are formed in vivo from phospholipid hydroxyalkenals but that lack CD36 binding activity.


Received for publication, April 27, 2006 , and in revised form, July 24, 2006.

* This work was supported by National Institutes of Health Grants P01 HL076491, P01 HL077107, HL70621, HL61878, GM21249, and HL53315 and supported in part by Cleveland Clinic Foundation General Clinical Research Center Grant M01 RR018390. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 Supported in part by a fellowship from the American Heart Association.

2 To whom correspondence should be addressed: Center for Cardiovascular Diagnostics and Prevention, Cleveland Clinic Foundation, 9500 Euclid Ave., NE-10, Cleveland, OH 44195. Tel.: 216-445-9763; Fax: 216-636-0392; E-mail: hazens{at}ccf.org.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
S. L. Hazen
Oxidized Phospholipids as Endogenous Pattern Recognition Ligands in Innate Immunity
J. Biol. Chem., June 6, 2008; 283(23): 15527 - 15531.
[Full Text] [PDF]


Home page
J. Lipid Res.Home page
X. Chen, W. Zhang, J. Laird, S. L. Hazen, and R. G. Salomon
Polyunsaturated phospholipids promote the oxidation and fragmentation of {gamma}-hydroxyalkenals: formation and reactions of oxidatively truncated ether phospholipids
J. Lipid Res., April 1, 2008; 49(4): 832 - 846.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2006 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement